Characteristics | No. (%) |
---|---|
All patients | 104 (100) |
Age (years; mean 56.2) | |
≤ 50 | 33 (32) |
51–60 | 29 (28) |
>60 | 42 (40) |
Menopause | |
Premenopausal | 30 (29) |
Postmenopausal | 74 (71) |
Grade | |
2 | 71 (68) |
3 | 33 (32) |
pTb | |
1 | 17 (16) |
2 | 86 (83) |
4 | 1 (1) |
pNb | |
0 | 29 (28) |
1 | 75 (72) |
pMb | |
0 | 104 (100) |
Stageb | |
I | 3 (3) |
IIa | 40 (38) |
IIb | 60 (58) |
IIIb | 1 (1) |
Histology | |
Ductal | 103 (99) |
Scirrhous | 1 (1) |
Therapya | |
Tamoxifen | 70 (67) |
Radiotherapy | 51 (49) |
Cyclophosphamide/Methotrexate/5-Fluorouracil | 28 (27) |
Cyclophosphamide/Adriamycin/5-Fluorouracil | 1 (1) |
Cyclophosphamide/Adriamycin | 1 (1) |
Progesterone | 1 (1) |
Letrozol | 1 (1) |